Novel Rapid Lateral Flow Immunoassay Can Function as `Suitcase Laboratory` for On-Site Detection of COVID-19 – HospiMedica

Scientists have developed a novel amplification-free rapid SARS-CoV-2 nucleic acid detection platform based on hybrid capture fluorescence immunoassay (HC-FIA) to fulfill the need for rapid and accurate nucleic acid detection at the point of care.The use of the monoclonal antibody S9.6 is the distinctive feature of this process developed by scientists from the Suzhou Institute of Biomedical Engineering and Technology (Suzhou, China). The process recognizes DNA-RNA double-stranded hybrids and enables…

Click here to view the original article.